Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- The team shrank two years in a row.
Revenue
€ 6.3 million
▲ 209% vs 2024
Profit
Caution€ -1.6 million
▲ 58% vs 2024
Debts
Normal€ 13.5 million
▼ 34% vs 2024
Inbiose from Gent, company number BE0534887593, closed financial year 2025 with a result of € -1.6 million after tax. For that financial year Inbiose recorded revenue of € 6.3 million and equity of € 3.6 million. Compared with financial year 2024, the result moved from € -3.8 million to € -1.6 million. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
What happened at Inbiose?
What happened at Inbiose in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Jakub Kalinowksi stepped down as director. NBB
- Pelin Yilmaz stepped down as director. NBB
- Joeri Beauprez stepped down as director. NBB
- Marcus Florent Oscar Zabeau stepped down as director. NBB
- Jean Prevot stepped down as director. NBB
- Soetaert BV stepped down as director. NBB
- Federale Participatie- en Investeringsmaatschappij - afgekort SFPIM stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 1.6 million. Source: NBB ↗
In short
From € 5.8 million loss in 2021 to € 1.6 million loss in 2025.
On average € 41,700 of value added per employee in 2022.
Pays suppliers within 85 days on average.
A new publication or filing at Inbiose? We notify you, reason included.
Follow InbioseNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Jakub Kalinowksi
Director
since 2026 · until 2032
since 2025 · until 2031
Pelin Yilmaz
Director
since 2026 · until 2032
since 2025 · until 2031
Jean Prevot
Director
since 2025 · until 2031
since 2025 · until 2031
Federale Participatie- en Investeringsmaatschappij - afgekort SFPIM
Director · represented by Goedele Ertveldt
Also active at: Aviapartner Belgium, Société Anonyme Belge de Constructions Aéronautiques, Société Nationale de Construction Aérospatiale +62 more
since 2025 · until 2031
Clemence Delcourt
Director
since 2025 · until 2026
Director · represented by Barbara Freitag
since 2025 · until 2025
Dirk Abeel Consulting BV
Director · represented by Dirk Abeel
since 2026 · until 2026
Establishments
Establishment units
Physical locations of this company
Technologiepark-Zwijnaarde 82 box 41
9052 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 26 companies are registered at this address.
CONTREL EUROPE
€ 250,724 gross margin · 2025
INCUBATIE- EN INNOVATIECENTRUM UNIVERSITEIT
€ 1.4 million gross margin · 2025
VP VENTURES
€ -1,670 gross margin · 2025
SENSNET
APCOR R&M
€ -12,717 gross margin · 2024
+21 more
Details
- Company number
- 0534.887.593
- VAT number
- BE 0534.887.593
- Registered office
- Technologiepark-Zwijnaarde 82 bus 41, 9052 Gent
- Names & denominations
- Inbiose
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 31 May 2013
- Peppol
- Active · Active since 4 Nov 2025
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van andere chemische producten, neg
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige zakelijke dienstverlening, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten